This flawed agreement is about protecting multinational corporation's rights. It does nothing to help workers or the environment.
Unifor’s campaign on the Trans-Pacific Partnership ramped up this week with a training session for regional coordinators from across Canada who will spend the summer building the union's top campaign.
Elementary logic suggests that deals (they're rarely called "free trade" deals any more) written in secret with only corporate figures present alongside governments will reflect -- guess who?
The CCPA finds that the TPP will be a real pain for improving our trade imbalance, employment, the manufacturing and high-tech sectors, and will keep the Canadian economy resource-based.
Big Pharma influences what doctors prescribe -- a practice that needs to change.
The federal Trans-Pacific Partnership hearings arrived in Toronto at a luxurious downtown hotel and were greeted by crowds of activists.
The House of Commons standing committee on international trade will be in Montreal, Quebec City, Windsor and Toronto and civil society will be there to let them know that they want the TPP stopped.
The TPP prohibits governments from requiring information about drug prices or R&D costs in connection with registration. Who wants to enforce a further lack of knowledge of drug prices or R&D costs?
Health Canada finally acknowledged what health economists, academics and activists had been saying for some time: drug costs will rise under pending trade deals like the TPP.
A new study from the CCPA finds that the TPP makes it easier for employers to hire migrant workers -- even in industries and regions where unemployment is high and domestic workers are available.